Calidi Biotherapeutics Inc (CLDI)
0.236
0.00 (0.00%)
USD |
NYAM |
May 10, 16:00
0.2363
0.00 (0.00%)
After-Hours: 20:00
Calidi Biotherapeutics Total Liabilities (Quarterly): 18.25M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 18.25M |
September 30, 2023 | 19.68M |
June 30, 2023 | 73.89M |
Date | Value |
---|---|
December 31, 2022 | 53.04M |
September 30, 2022 | 45.54M |
December 31, 2021 | 35.00M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
18.25M
Minimum
Dec 2023
73.89M
Maximum
Jun 2023
40.90M
Average
40.27M
Median
Total Liabilities (Quarterly) Benchmarks
Minerva Neurosciences Inc | 87.10M |
Viking Therapeutics Inc | 33.63M |
CytomX Therapeutics Inc | 249.24M |
Genprex Inc | 3.254M |
Janux Therapeutics Inc | 36.06M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 10.02M |
Shareholders Equity (Quarterly) | -8.235M |